Eugène van Puijenbroek is a medical doctor and clinical pharmacologist who has been working at the Netherlands Pharmacovigilance Centre Lareb since 1994. In 2001 he obtained a PhD degree at the Department of Pharmacotherapy and Pharmacoepidemiology at the Utrecht Institute for Pharmaceutical Sciences, University of Utrecht, the Netherlands. Since April 2014 he is professor of pharmacovigilance at the Faculty of Science and Engineering, Department of PharmacoTherapy, -Epidemiology and -Economics of the University of Groningen, the Netherlands. He obtained a vast experience analysing signals in the spontaneous reporting system of the Netherlands and published in national as well as international journals. Next to his work in pharmacovigilance he has been working as a general practitioner from 1991 till 2006.
His current field of attention is the development of signal detection methodologies, especially the integration of the statistical approach combined with the use of clinical information. He was a member of the Executive Board of the International Society of Pharmacovigilance from 2006 till 2012 and is currently member of the ISoP Scientific Board. He was co-opted member of the Pharmacovigilance Working Party of the European Medicines Agency from 2010 till 2012. He is a member of the editorial board of Drug Safety since 2001 and Chair of the Signal Management Review Technical Working Group Methods Work stream of the European Medicines Agency.
Eugène van Puijenbroek has been coordinating national and international studies focussing on the safety of drugs. He coordinated postgraduate training courses on pharmacovigilance and supervises several PhD students working in the field of Drug Safety.